Skip to content

The Study is an Observational Post-market Follow-up Program to Evaluate Long Term (5 Years) Safety of Mentor Breast Implants in Chinese Population

MNT202401: Post Market Clinical Follow up for Mentor Breast Implants

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06510205
Enrollment
6111
Registered
2024-07-19
Start date
2024-07-14
Completion date
2034-12-31
Last updated
2026-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Augmentation, Mammaplasty

Brief summary

The Mentor Post-Market Clinical Follow-Up Study is a multicenter observational study conducted in China. It aims to collect safety data on Mentor breast implants over a 5-year follow-up period in the Chinese population. In addition to safety data, the study will also gather information on postoperative pain and participant satisfaction levels. The objective is to explore customers' clinical experiences and use them as a reference for future product development. The study intends to enroll different number of participants for each license.

Interventions

DEVICEMentor Breast implants

Mentor breast implants are circular or waterdrop-shaped devices with shells made of successive cross-linked layers of silicone elastomer. The shell is filled with Mentor's proprietary formulation of silicone gel. Mentor breast implants are available in smooth and textured shells, both supplied in sterile form.

Sponsors

Johnson & Johnson Medical (Shanghai) Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. Women who have received Mentor breast implants per product instructions; 2. Participants must possess the ability to comprehend the study procedures, give consent for the use of their preoperative and surgical data, and agree to take part in postoperative follow-up assessments. Additionally, they should possess the necessary civil capacity, be capable of reading and writing, and willingly provide informed consent by signing the consent form. 3. Aged not less than 18 years at the time of implantation surgery (for products with registration license Guoxie Zhujin 20223130323, the participant's age should be not less than 22 years).

Exclusion criteria

* Not applicable

Design outcomes

Primary

MeasureTime frameDescription
Breast implant related AEsUp to 5 yearsPost-op 1 month, 3 months, 1 year, 2 years, 3 years, 4 years, 5 years

Secondary

MeasureTime frameDescription
Numerical Pain Scale assessment1 month after surgeryZero means you have no pain, while 10 represents the most intense pain possible.
Customer Satisfaction Score measurementUp to 5 years after surgeryMeasured at 1 month, 3 months, 1 year, 2 years, 3 years, 4 years, 5 years after surgery Using a 5-point scoring scale, 5 means very satisfied while 1 means very disatisfied.

Countries

China

Contacts

CONTACTStudy Contact
ygu51@its.jnj.com+86 15692105615
STUDY_DIRECTORHuimin Wu

Shenzhen Junke Medical Cosmetology Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 29, 2026